USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ

USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ

Abstract Anaplastic thyroid cancer (ATC) is one of the most lethal and aggressive human malignancies, with no effective treatment currently available. The Hippo tumor suppressor pathway is highly conserved in mammals and plays an important role in carcinogenesis. TAZ is one of major key effectors of...

Full description

Bibliographic Details
Main Authors:	Jianing Tang, Yongwen Luo, Liang Xiao
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-04-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-022-04781-1

Similar Items

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
by: Jin Li, et al.
Published: (2022-08-01)

USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer
by: Ashley Mussell, et al.
Published: (2020-10-01)

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
by: Dongyi Liu, et al.
Published: (2023-04-01)

USP14 promotes colorectal cancer progression by targeting JNK for stabilization
by: Xue-Hua Du, et al.
Published: (2023-01-01)

Research progress of immunotherapy against anaplastic thyroid cancer
by: Jiaqian Chen, et al.
Published: (2024-03-01)

MINDY1 promotes bladder cancer progression by stabilizing YAP
by: Yongwen Luo, et al.
Published: (2021-07-01)

Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
by: Meijia Qian, et al.
Published: (2021-12-01)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
by: Jieun Lee, et al.
Published: (2013-06-01)

MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1
by: Wei Zhang, et al.
Published: (2019-11-01)

MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
by: Jianing Tang, et al.
Published: (2021-10-01)

CTHRC1 promotes anaplastic thyroid cancer progression by upregulating the proliferation, migration, and invasion of tumor cells
by: Yong Chen, et al.
Published: (2023-05-01)

Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
by: Jianing Tang, et al.
Published: (2022-01-01)

The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
by: Xiaohong Xia, et al.
Published: (2021-03-01)

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer
by: Caitlin O. Caperton, et al.
Published: (2021-03-01)

Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
by: Cinzia Antognelli, et al.
Published: (2019-06-01)

Anaplastic cancer of the thyroid: The viper in the pit
by: Krishna G Seshadri
Published: (2019-01-01)

Anaplastic thyroid carcinoma
by: Noel Ernesto Pedraza Alonso, et al.
Published: (2012-02-01)

ANAPLASTIC THYROID CARCINOMA
by: Augusto eTaccaliti, et al.
Published: (2012-07-01)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
by: Xiaolin Zhu, et al.
Published: (2021-07-01)

Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration
by: Jiaqi Ji, et al.
Published: (2021-04-01)

PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression
by: Zi-Mei Peng, et al.
Published: (2024-01-01)

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
by: Jin-Seok Lee, et al.
Published: (2022-11-01)

Immunotherapy in anaplastic thyroid cancer: Case series
by: Shyang-Rong Shih, et al.
Published: (2022-06-01)

USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization
by: Jianing Tang, et al.
Published: (2023-06-01)

USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression
by: Weiwei Wang, et al.
Published: (2023-01-01)

USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein
by: Hui-hui Zhang, et al.
Published: (2024-01-01)

USP12 facilitates gastric cancer progression via stabilizing YAP
by: Peng Zhang, et al.
Published: (2024-04-01)

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
by: Jianing Tang, et al.
Published: (2023-11-01)

Anaplastic Thyroid Carcinoma: An Update
by: Arnaud Jannin, et al.
Published: (2022-02-01)

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer
by: McFadden, David Glenn, et al.
Published: (2014)

Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
by: Soo Young Kim, et al.
Published: (2020-09-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

New opportunities for preoperative diagnosis of anaplastic thyroid cancer
by: S. A. Lukyanov, et al.
Published: (2021-04-01)

Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
by: A. L. Pylev, et al.
Published: (2020-04-01)

Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
by: Van Allen, Eliezer M., et al.
Published: (2017)

Efficacy of lenvatinib in a patient with anaplastic thyroid cancer
by: Kazuyuki Oishi, et al.
Published: (2017-05-01)

Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer
by: Sasan Fazeli MD, et al.
Published: (2019-11-01)

Immunotherapy in Anaplastic Thyroid Cancer: Much Yet to Be Learned
by: Keith C. Bible, MD, PhD
Published: (2021-09-01)

Everolimus in Anaplastic Thyroid Cancer: A Case Series
by: Ethan J. Harris, et al.
Published: (2019-02-01)

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
by: Martina Tavarelli, et al.
Published: (2017-10-01)